Organon Acquired by Sun Pharmaceutical Holdings USA | Healthcare M&A Deal

Sun Pharmaceutical Holdings USA has agreed to acquire Organon, a pharmacy business in New Jersey, for $14.00 per share. Organon is a healthcare company with operations tied to pharmacy products, and the merger acquisition would make Organon a wholly owned subsidiary of Sun Pharmaceutical Holdings USA. Sun Pharmaceutical Holdings USA acquisitions in healthcare M&A expand its strategic acquisition footprint through a merger acquisition structure using a wholly owned Merger Sub. The announced strategic acquisition is documented in a SEC preliminary proxy filing, with Organon common stock converted into cash at $14.00 per share, excluding shares held by affiliates and valid dissenters under Delaware appraisal rights.